This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Avedro, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Rajesh K Rajpal in Corneal Treatments
Introduction
Rajesh K Rajpal is an accomplished inventor based in McLean, VA (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of corneal ectatic disorders. With a total of 2 patents, his work focuses on innovative systems and formulations that enhance eye treatments.
Latest Patents
Rajpal's latest patents include groundbreaking systems and methods for treating corneal ectatic disorders. These systems precisely apply photoactivating light to specific areas of the cornea that have been treated with a cross-linking agent. One notable system features a light source that delivers photoactivating light to activate the cross-linking agent applied to the eye. The system is designed with optical elements that transmit the light according to a defined pattern of treatment zones. Each zone delivers different doses of light, with the first zone providing a greater dose than the second.
Additionally, Rajpal has developed formulations for eye treatments that include therapeutic agents and delivery agents. These formulations are designed to enhance the permeability of the corneal epithelium and effectively deliver therapeutic agents to the stroma. The methods involve applying preparatory formulations that include various enzymes and agents to optimize treatment outcomes.
Career Highlights
Rajesh K Rajpal is currently associated with Avedro, Inc., where he continues to innovate in the field of eye care. His work has been instrumental in advancing treatment options for patients suffering from corneal disorders.
Collaborations
Throughout his career, Rajpal has collaborated with notable professionals in the field, including Pavel Kamaev and Marc David Friedman. These collaborations have further enriched his research and development efforts.
Conclusion
Rajesh K Rajpal's contributions to ophthalmology through his patents and innovative treatments have the potential to significantly improve patient outcomes. His dedication to advancing eye care technology is commendable and highlights the importance of innovation in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile